ANNUAL REPORT FY 20 NOTES
HUGE EXPANSION PLANS
1- Capacity of Existing Plant of Active Ingredient(A I) to be increased from 10000 MT/Year to be increased to 25000 MT/Year of AI & Intermediates.
2-NACL Multichem Ltd ,100% subsidiary of NACL to manufacture 38000 MT/Year of AI(Technicals) & Speciality Chemicals in phases.
3-NACL Spec Chem Industries Ltd another 100% subsidiary of NACL to set up greenfield project of AI & intermediates Capacity 25000 MT/Year.
Identification of good Products & expansion with less leverage will be key.
During the year 19-20 , company has successfully commenced manufacture of two new AI namely Lambda Cyhalothrin an insecticide and Bispyribac Sodium, a herbicide. Company also introduced 8 new formulated products.
Company has appealed to Govt of India against proposed ban of Tricylazole.
Some bio products are being tested to move towards environmentally safe products.
TURNOVER & EBIDTA
Turnover grew from 857 Cr in 18-19 to 1003 cr in 19-20 , a growth of 17%.Domestic Sales of 746Cr (Formulated Sales 440 Cr) against 633 Cr in 18-19. Export Sales 257 Cr as compared to 224 Cr in 18-19.
EBIDTA grew from 39.41 cr in 18-19 to 76.07 cr in 19-20 a growth of 93%. EBIDTA margin is less than 8%. This needs to be improved , lower as compared to other player.
Disc Invested
1 Like